2 Cheap Canadian Stocks I’d Buy This December

Value-seeking investors can consider gaining exposure to small-cap stocks such as Equinox Gold and BioSyent.

While the stock market is hovering near all-time highs, investors can still buy and hold quality companies trading at a discount to their intrinsic value. In this article, I have identified two undervalued Canadian stocks you can buy today and generate outsized returns in 2025 and beyond. Let’s dive deeper.

Workers use a microscope to do medical research in a modern laboratory.

Source: Getty Images

BioSyent stock

BioSyent (TSXV: RX) is a specialty pharmaceutical company with a market cap of $133.6 million. It sources, acquires, develops, and sells healthcare products in Canada and other international markets. Its products include iron supplements and lubricants for various procedures, such as endoscopy and proctoscopy.

In the last 12 months, BioSyent has reported revenue of $34.5 million, an increase of 12% year over year. Its revenue has almost tripled from $12.2 million in 2014. Moreover, the company reports a consistent profit due to a healthy gross margin of 79.4% and an operating margin of 24%. A debt-free balance sheet allows BioSyent to report a free cash flow of $6.7 million in the last four quarters, indicating a margin of 19.4%.

Notably, the healthcare stock has reported positive earnings per share for 57 consecutive quarters. Analysts tracking the Canadian company project earnings to expand to $0.63 per share in 2024 and $0.9 per share in 2026, up from $0.53 per share in 2023.

BioSyent’s revenue is forecast to surpass $45 million in 2026. Given a free cash flow margin of 20%, BioSyent might end 2026 with an FCF of $9 million. Priced at 20 times forward FCF, BioSyent stock could gain 35% over the next 12 months.

BioSyent also pays shareholders an annual dividend of $0.18 per share, indicating a forward yield of 1.5%. The payout has increased by 12% in the past year. Investors can expect its dividend growth to continue as the company has a payout ratio of just 31%.

Equinox Gold stock

Valued at a market cap of $2.6 billion, Equinox Gold (TSX: EQX) is engaged in acquiring, exploring, and developing mineral properties. It explores gold and silver deposits with mining interests in Brazil, the U.S., and Mexico.

In Q3 of 2024, Equinox Gold realized US$2,461 per ounce on the 174,000 ounces it sold, bringing in US$428 million in total sales. The increase in sales was attributed to higher production and rising gold prices. The Greenstone mine, under construction last year, contributed 44,000 ounces in Q3 and will be a key driver of sales over the next 12 months.

Higher sales and a focus on cost optimization allowed Equinox to report US$101 million in income from mine operations, up from $76 million in the year-ago period.

While gold prices have rallied over 30% in 2024, the TSX stock has seen a 25% uptick in share prices this year. Higher commodity prices will allow Equinox Gold to end 2025 with an adjusted earnings per share of US$1, up from US$0.24 in 2024 and US$0.07 in 2023.

Priced at 7.8 times forward earnings, Equinox Gold stock is cheap and could be part of your equity portfolio at current prices. Analysts remain bullish on EQX stock and expect it to gain 36% according to consensus price target estimates.

Fool contributor Aditya Raghunath has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends BioSyent. The Motley Fool has a disclosure policy.

More on Stock Market

tsx today
Stock Market

TSX Today: What to Watch for in Stocks on Friday, November 20

TSX investors will closely watch falling commodity prices today, while escalating U.S.-Iran tensions, Canada-U.S. trade negotiations, and major telecom takeover…

Read more »

industrial worker on construction site laying sealant for waterproofing cement
Stock Market

1 Canadian Stock to Rule Them All in 2027

Explore the powerful stocks of 2027 that dominated the market through strategic partnerships and innovation.

Read more »

tsx today
Stock Market

TSX Today: What to Watch for in Stocks on Thursday, November 19

The TSX could remain volatile today after falling for five consecutive sessions, as recovering oil prices offer some support while…

Read more »

man in business suit pulls a piece out of wobbly wooden tower
Dividend Stocks

Overlooked Canadian Stocks Worth a Closer Look

Explore overlooked Canadian stocks North West Company and West Fraser, with essential retail demand and potential housing recovery upside.

Read more »

Oil industry worker works in oilfield
Energy Stocks

Canadian Natural Resources Has Raised Its Dividend for 26 Straight Years: Here’s Why It Stands Out

Canadian Natural Resources has raised its dividend for 26 straight years. Explore the assets and cash flow supporting its growing…

Read more »

tsx today
Stock Market

TSX Today: Why the Canadian Stock Market Sell-off Could Intensify on Wednesday, November 18

The TSX could extend its losing streak at the open today as gold and silver prices tumble to their lowest…

Read more »

tsx today
Stock Market

TSX Today: What to Watch for in Stocks on Tuesday, November 17

The TSX could remain volatile at the open today as investors digest Quebecor's proposed Telus takeover and Canadian Natural's Advantage…

Read more »

up arrow on wooden blocks
Dividend Stocks

Standout Canadian Blue-Chip Stocks to Own in 2027

Explore Canadian blue-chip stocks for 2027, with Canadian National, Fortis and Manulife offering distinct paths to earnings growth and dividend…

Read more »